EP Patent

EP1778618A2 — Synthesis of triethylenetetramines

Assigned to PHILERA NEW ZEALAND Ltd · Expires 2007-05-02 · 19y expired

What this patent protects

Methods and intermediates for synthesizing triethylenetetramine and salts thereof, as well as novel triethylenetetramine salts and their crystal structure, and triethylenetetramine salts of high purity.

USPTO Abstract

Methods and intermediates for synthesizing triethylenetetramine and salts thereof, as well as novel triethylenetetramine salts and their crystal structure, and triethylenetetramine salts of high purity.

Drugs covered by this patent

Patent Metadata

Patent number
EP1778618A2
Jurisdiction
EP
Classification
Expires
2007-05-02
Drug substance claim
No
Drug product claim
No
Assignee
PHILERA NEW ZEALAND Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.